309 related articles for article (PubMed ID: 27545990)
21. Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report.
Cherrier MM; Craft S; Matsumoto AH
J Androl; 2003; 24(4):568-76. PubMed ID: 12826696
[TBL] [Abstract][Full Text] [Related]
22. Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.
Doğan BA; Karakılıç E; Tuna MM; Arduç A; Berker D; Güler S
Clin Endocrinol (Oxf); 2015 Mar; 82(3):422-8. PubMed ID: 25280063
[TBL] [Abstract][Full Text] [Related]
23. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
24. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
[TBL] [Abstract][Full Text] [Related]
26. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
Shigehara K; Konaka H; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Iwamoto T; Koh E; Mizokami A; Namiki M
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
[TBL] [Abstract][Full Text] [Related]
27. Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy.
Perry PJ; Lund BC; Arndt S; Holman T; Bever-Stille KA; Paulsen J; Demers LM
Ann Clin Psychiatry; 2001 Jun; 13(2):75-80. PubMed ID: 11534928
[TBL] [Abstract][Full Text] [Related]
28. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
Swerdloff RS; Wang C
Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
[TBL] [Abstract][Full Text] [Related]
29. [Effect of transderrmal testosterone on the quality of life of men with androgen deficiency and chronic prostatitis in routine clinical practice].
Vinarov AZ; Rozhivanov RV
Urologiia; 2018 Mar; (1):71-76. PubMed ID: 29634137
[TBL] [Abstract][Full Text] [Related]
30. Testosterone supplementation in hypogonadal men: our personal experience.
Giuberti A; Picozzi SC; Mazza L; Casu M; Viganò P; Manganini V; Strada GR
Arch Ital Urol Androl; 2005 Dec; 77(4):191-3. PubMed ID: 16444930
[TBL] [Abstract][Full Text] [Related]
31. [Hormone replacement therapy in men: practical aspects].
Gamidov SI; Shcherbakov DV; Tazhetdinov OKh; Pavlovichev AA; Iremashvili VV
Urologiia; 2011; (4):68, 70-3. PubMed ID: 22066247
[No Abstract] [Full Text] [Related]
32. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
[TBL] [Abstract][Full Text] [Related]
33. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
34. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
[TBL] [Abstract][Full Text] [Related]
35. Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy.
Bhasin S; Seidman S; Travison TG; Pencina KM; Lincoff AM; Nissen SE; Miller MG; Flevaris P; Li X; Wannemuehler KA; Pope HG
J Clin Endocrinol Metab; 2024 Jun; 109(7):1814-1826. PubMed ID: 38205962
[TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy and longevity.
Comhaire F
Andrologia; 2016 Feb; 48(1):65-8. PubMed ID: 25892327
[TBL] [Abstract][Full Text] [Related]
37. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
38. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
Bauman WA; Cirnigliaro CM; La Fountaine MF; Jensen AM; Wecht JM; Kirshblum SC; Spungen AM
Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
[TBL] [Abstract][Full Text] [Related]
39. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire.
Gelhorn HL; Dashiell-Aje E; Miller MG; DeRogatis LR; Dobs A; Seftel AD; Althof SE; Brod M; Revicki DA
J Sex Med; 2016 Nov; 13(11):1737-1749. PubMed ID: 27692845
[TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
